Clip 1. Can you just briefly explain to us what the EMCDDA is? Who set it up? Who funds it, and to whom does it report? [EU, European Parliament, Norway, Turkey]

Clip 2. How has the EMCDDA's role and status changed in recent times, particularly with the new regulation and mission statement? [Regulation recast, extension to polydrug use, new drugs and Early Warning System, best practice]

Clip 3. Can you tell us something about cooperation with other European institutions and, in the drugs field, beyond it? [European Commission, European Parliament, Europol, ECDC, EMEA, UNODC, World Customs Organization, Interpol, MAOC-N]

Clip 4. What about the Annual Report – what is its purpose and what does it contain? [drug facts and analysis, Europe-wide and by country, trends and responses, Selected issues, Statistical bulletin]

Clip 5. Many members of the general public may have the impression that drug use is something that just keeps on rising, but this year’s Report shows a more complex pattern, doesn’t it?[strong inter-country variation and varied picutre across age groups, yet stagnation or fall in heroin use, cannabis use seems to have stabilised]

Clip 6. In relation to cannabis, there seem to be significant worries about the health impact of its use. [focus on intensive use patterns; fast-rising demand for treatment for cannabis use; potency link may be overstated]

Clip 7. What about heroin? Is there any sign of demand for all types of cocaine levelling off? Use seems to be stagnant, but here again, the picture varies across Europe and between age groups. What are the likely trends?

Clip 8. You’ve chosen cocaine and crack cocaine use as one of three Selected Issues this year. Why and what was found? Is cocaine the drug of choice for social users? [different types of cocaine users: socially well-integrated, opiate co-use, marginalised crack users in some European cities]

Clip 10. There have for some years been fears of a crack epidemic in Europe. What’s the situation?

Clip 11. There have been record cocaine seizures of late. Are these a true reflection of the situation?[trafficking seizures one of various sources of supply-side data, new modes of research such as metabolites in waste water]

Clip 12. What is being done to combat trends in trafficking, most recently through western Africa?

Clip 13. For many drugs, the impact on the individual’s and public health is a big concern. What are the trends and geographical variations in HIV and other infection rates, in the case of injecting drug users?[Baltic States and Portugal; HepC 'hidden infections', HIV-transmission; positive results due to treatment and harm reduction measures]

Clip 14. You mentioned the importance of harm reduction measures. What are they?

Clip 15. What about drug-related deaths? There doesn’t seem much progress there. And do the published figures tell the full story? How is polydrug use – the habitual use of several drugs at the same time – a factor?

Clip 16. The second of the two Selected Issues this year is drugs and driving. Is this more common than it used to or is more attention just being paid to it? How has the legislative and judicial response varied across Europe and what results has it brought?

Clip 20. Drug use and the response to it still varies across Europe. Where is there consensus on policy, and is it growing or shrinking?

Clip 21. How is this consensus, and Europe’s data and analysis, being fed into international forums? [EMCDDA mandate, international cooperation: NIDA, UNODC; Ungass evaluation, EMCDDA's role is as main data provider for Europe]